Dr. Khanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Mount Auburn St
Cambridge, MA 02138Phone+1 617-492-3500
Education & Training
Mount Auburn HospitalResidency, Internal Medicine, 2018 - 2021
Beth Israel Deaconess Medical CenterPost-Doctoral Fellowship, Hematology and Medical Oncology, 2014 - 2018
Delhi University College of Medical SciencesClass of 2014
Certifications & Licensure
MA State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 30 citationsACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma.Prateek Khanna, Hong Jie Soh, Chun-Hau Chen, Ruchi Saxena, Seema Amin
Science Translational Medicine. 2021-01-20 - 1 citationsTFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma.Jiao Li, Kaimeng Huang, Fiona McBride, Ananthan Sadagopan, Daniel S Gallant
Biorxiv. 2024-08-10 - 12 citationsStudy of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts.Chun-Hau Chen, Swati S. Bhasin, Prateek Khanna, Joshi M, Joslin Pm
Oncogenesis. 2019-02-22
Journal Articles
- Study of Cathepsin B Inhibition in VEGFR TKI Treated Human Renal Cell Carcinoma XenograftsDavid A Frank, Rupal S Bhatt, Seth L Alper, Prateek Khanna, Nature
Press Mentions
KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
